section name header

Table 83-3

Recommendations for the Treatment of Syphilisa

Stage of SyphilisPatients without Penicillin AllergyPatients with Confirmed Penicillin Allergyb
Primary, secondary, or early latentCSF normal or not examined:Penicillin G benzathine (single dose of 2.4 mU IM)CSF normal or not examined:Tetracycline HCl (500 mg PO qid) or doxycycline (100 mg PO bid) for 2 weeks
CSF abnormal: Treat as neurosyphilisCSF abnormal: Treat as neurosyphilis
Late latent (or latent of uncertain duration), cardiovascular, or benign tertiary

CSF normal or not examined: Penicillin G benzathine (2.4 mU IM weekly for 3 weeks)

CSF abnormal: Treat as neurosyphilis

CSF normal and pt not infected with HIV: Tetracycline HCl (500 mg PO qid) or doxycycline (100 mg PO bid) for 4 weeks

CSF normal and pt infected with HIV: Desensitization and treatment with penicillin if compliance cannot be ensured

CSF abnormal: Treat as neurosyphilis

Neurosyphilis (asymptomatic or symptomatic)

Aqueous crystalline penicillin G (18-24 mU/d IV, given as 3-4 mU q4h or continuous infusion) for 10-14 days

or

Aqueous procaine penicillin G (2.4 mU/d IM) plus oral probenecid (500 mg qid), both for 10-14 days

Desensitization and treatment with penicillinc
Syphilis in pregnancyAccording to stageDesensitization and treatment with penicillin

aSee text for indications for CSF examination.

bBecause of the documented presence of macrolide resistance in many T. pallidum strains in North America, Europe, and China, azithromycin or other macrolides should be used with caution only when treatment with penicillin or doxycycline is not feasible. Azithromycin should not be used for men who have sex with men or for pregnant women.

cLimited data suggest that ceftriaxone (2 g/d either IM or IV for 10-14 days) can be used; however, cross-reactivity between penicillin and ceftriaxone is possible.

Abbreviations: mU, million units.

Source: Adapted from the 2010 Sexually Transmitted Diseases Treatment Guidelines from the Centers for Disease Control and Prevention.